Jazz Pharmaceuticals Plc - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated January 14, 2010, reports on a corporate overview presentation delivered by Jazz Pharmaceuticals, Inc. at the J.P. Morgan Healthcare Conference in San Francisco. The presentation included financial information relating to completed quarterly periods in fiscal 2009. The filing serves to disclose this information to the public via an audio webcast and accompanying slides.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Instead, it discloses the presentation of a non-GAAP financial measure termed "Adjusted EPS." This metric excludes amortization of intangible assets, non-cash interest expense, contract revenues, and stock-based compensation from GAAP diluted net income per share. Reconciliations between Adjusted EPS and GAAP EPS for the relevant periods are contained in Exhibit 99.1, which is not included in the provided text.
Material Changes and Management Commentary
Management commentary indicates that Adjusted EPS is presented to reflect cash generation in ongoing operations and to facilitate analysis of core operating results across reporting periods. The company explicitly states that this non-GAAP measure may not be directly comparable to similarly titled measures used by other companies and should be considered in addition to, not as a substitute for, GAAP financial measures. No specific material changes in financial condition or operations are detailed in the text of this filing.
Risks and Contingencies
The filing includes a standard disclaimer that the information contained in Item 2.02 and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into any other SEC filings. No specific operational risks or legal contingencies are detailed in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (slides and transcript) to obtain specific numerical values for Adjusted EPS and GAAP EPS reconciliations.
- Verify the specific quarterly periods in fiscal 2009 covered by the presentation.
- Compare the company's definition of Adjusted EPS against industry peers to assess comparability.
- Confirm the impact of excluded items (amortization, non-cash interest, stock-based compensation) on the company's reported GAAP results.